TEVA - Teva Pharmaceutical ...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $8.12 | Open | $8.10 |
| Volume | 16.16M | Market Cap | 9.657B |
| Yield | Last Dividend |
| Teva Pharmaceutical Industries : Update ... | 04/01/20 |
| April 01, 2020 As a leading global pharmaceutical company, Teva provides essential medicines to millions of patients around??? | April 1, 2020 | |
| US court rules for Teva in migraine pate... | 03/31/20 |
| Teva Pharmaceutical Industries Ltd on Tuesday won a ruling from a U.S. administrative court that helps preserve its rights to the migraine drug Ajovy. | |
| Global Epinephrine Market Insights, 2019... | 03/31/20 |
| DUBLIN--(BUSINESS WIRE)--The "Epinephrine Market to 2027 - Global Analysis and Forecasts By Product Type; Application; Distribution Channel; and Geogr... | |
| It???s time to see Teva Pharmaceuticals ... | 03/24/20 |
| Shares of Teva Pharmaceuticals (NYSE: TEVA) fell to a new low this month as markets across the world continued to be battered by the raging covid-19 p... | |
| Teva to donate 6M doses of malaria drug ... | 03/19/20 |
| Teva Pharmaceutical Industries (NYSE:TEVA) announces the immediate donation of 6M doses of malaria med hydroxychloroquine sulfate tablets through whol... | |
| Teva to Donate Potential COVID-19 Treatm... | 03/19/20 |
| TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation... | |
| Positive Recommendation by NICE for firs... | 03/12/20 |
| TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Europe BV an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today annou... | |
| IN BRIEF: U.S. Supreme Court lifts stay ... | 03/06/20 |
| The U.S. Supreme Court on Friday cleared the way for states and private plaintiffs to obtain millions of pages of records from Teva Pharmaceutical Ind... | |
| The Daily Biotech Pulse: GenMark Diagnos... | 03/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 2) ... | |
| These Two Drug Stocks are Dirt Cheap | 03/03/20 |
| The market???s freefall in the last week led to the blatant of good companies. Bausch Health (NYSE:BHC) lost 16.5% last week while Teva Pharmaceutical... | |
| The future of these 7 biotechs hinges on... | 02/25/20 |
| There are about 70 drugs in clinical testing for NASH, a fatty liver disease that affects millions of Americans and is a top cause of liver transplant... | |
| The Zacks Analyst Blog Highlights: Johns... | 02/24/20 |
| The Zacks Analyst Blog Highlights: Johnson & Johnson, Bayer Aktiengesellschaft, Pfizer, Mylan N.V. and Teva Pharmaceutical Industries | |
| Teva Pharmaceutical Industries : Gets FD... | 02/24/20 |
| By Michael Dabaie Teva Respiratory LLC, an affiliate of Teva Pharmaceutical Industries Ltd., said the U.S. Food and Drug Administration has approved A... | |
| Teva gets FDA approval of ArmonAir Digih... | 02/24/20 |
| The U.S. Food and Drug Administration approves Teva's (NYSE:TEVA) ArmonAir Digihaler (fluticasone propionate) Inhalation Powder, and inhaled coriticos... | |
| Teva Announces FDA Approval of ArmonAir?... | 02/24/20 |
| TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Respiratory, LLC, an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announc... | |
| Teva Announces Registration Trials of De... | 02/19/20 |
| TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Phase 2/3 ARTISTS 1 and Phase 3 ARTIS... | |
| Teva Pharm CEO hopes to launch Huntingto... | 02/19/20 |
| Israel-based Teva Pharmaceutical Industries hopes to receive approval to launch its Huntington's treatment Austedo in China this year, the company's c... | |
| TEVA Stock is a Buy but Not an Easy One | 02/19/20 |
| TEVA stock is an ugly name in an even uglier industry. However, it???s also vital to our healthcare system, making it a rough buy. | |
| 3 Analysts Dissect Teva's Q4 Results | 02/13/20 |
| Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) reported fourth-quarter sales and revenues that slightly exceeded estimates but issued a guarded outl... | |
| Good piece exploring whether the recent ... | 02/13/20 |
| Good piece exploring whether the recent signs of a turnaround at Teva Pharmaceuticals are real. ??? | |
| Teva Pharmaceutical CEO on Bringing His ... | 02/12/20 |
| Teva Pharmaceutical Industries CEO K??re Schultz talked with Barron???s about opioid litigation, stabilizing revenues, and what???s next for the compa... | |
| Teva Pharmaceuticals Earnings: TEVA Stoc... | 02/12/20 |
| Teva Pharmaceuticals (TEVA) earnings for the pharmaceutical company's fourth quarter of 2019 have TEVA stock taking off on Wednesday. | |
| Teva Pharmaceuticals Overtakes Key Level... | 02/12/20 |
| The equity is also filling a mid-May bear gap | |
| Thinking about buying stock in Canopy Gr... | 02/12/20 |
| NEW YORK, Feb. 12, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CGC, MU, ROKU, SPWR, and TEVA. To see how InvestorsObs... | |
| Teva's stock falls on earnings; Copaxone... | 02/12/20 |
| Shares of Teva Pharmaceutical Industries Ltd. were down 1% in premarket trading on Wednesday after the Israeli drugmaker reported earnings of $110 mil... | |
| New Report Shows Teva Generic Medicines ... | 02/12/20 |
| Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) released a new economic impact report detailing the billions of dollars saved by Teva???s ge... | |
| Teva Reports Fourth Quarter and Full Yea... | 02/12/20 |
| Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the year and the quarter ended December 31, 2019. Full-Year 2019 | |
| Sell rating | 04/02/20 |
| Morgan Stanley maintains Underweight rating and lowers Price Target from $13.00 to $8.00 | |
| Underperform rating | 03/23/20 |
| B of A Securities maintains Underperform rating and lowers Price Target from $11.00 to $7.00 | |
| Hold rating | 03/05/20 |
| Wells Fargo maintains Equal-Weight rating and raises Price Target from $10.00 to $12.00 | |
| Buy rating | 02/18/20 |
| Argus Research maintains Buy rating and raises Price Target from $10.00 to $15.00 | |
| Sell rating | 02/14/20 |
| Morgan Stanley maintains Underweight rating and raises Price Target from $8.00 to $13.00 | |
| Strong Buy rating | 02/13/20 |
| Oppenheimer maintains Outperform rating and raises Price Target from $12.00 to $16.00 | |
| Hold rating | 02/13/20 |
| SunTrust Robinson Humphrey maintains Hold rating and raises Price Target from $9.00 to $13.00 | |
| Underperform rating | 02/13/20 |
| B of A Securities maintains Underperform rating and raises Price Target from $8.00 to $11.00 | |
| Hold rating | 02/12/20 |
| CFRA maintains Hold rating and raises Price Target from $11.00 to $13.00 | |
| Hold rating | 02/12/20 |
| Cantor Fitzgerald maintains Neutral rating and raises Price Target from $9.00 to $15.00 | |
| Hold rating | 01/22/20 |
| Wells Fargo maintains Equal-Weight rating and raises Price Target from $8.00 to $10.00 | |
| Hold rating | 11/08/19 |
| PiperJaffray maintains Neutral rating and raises Price Target from $6.00 to $7.00 | |
| Date | 2020-02-12 (BMO) | Est. (EPS/Rev.) | $0.61/ 4.35B |
| Actual (EPS/Rev.) | $0.62/ $4.47 B | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Free Biotech Holdings | Scientia Equity Research | 100.00 % | Follow |
| Trading | Trading | 99.00 % | Follow |
| Swing for the fences | Gino Baldassano | 73.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
